{"DataElement":{"publicId":"10672200","version":"1","preferredName":"Union for International Cancer Control TNM Staging System Clinical Stage","preferredDefinition":"The clinical disease stage of the neoplasm based on the Union for International Cancer Control TNM Staging System.","longName":"10544812v1.00:10672190v1.00","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"10544812","version":"1","preferredName":"Union for International Cancer Control TNM Staging System Clinical Examination Stage Grouping","preferredDefinition":"_The International Union Against Cancer (UICC) is the only global cancer organisation with members and activities covering all aspects of cancer control. Founded in 1933, UICC is an independent, international, non-governmental association of 291 member cancer fighting organizations in 87 countries. Located in Geneva, Switzerland._A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._A formal or careful inspection of an object or subject._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"10544794v1.00:10544811v1.00","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"10544794","version":"1","preferredName":"International Union Against Cancer TNM Staging System","preferredDefinition":"The International Union Against Cancer (UICC) is the only global cancer organisation with members and activities covering all aspects of cancer control. Founded in 1933, UICC is an independent, international, non-governmental association of 291 member cancer fighting organizations in 87 countries. Located in Geneva, Switzerland._A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","longName":"C39434:C25384","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Union for International Cancer Control","conceptCode":"C39434","definition":"A global cancer organisation comprising over 1200 organisations in 172 countries with activities covering all aspects of cancer control. It was founded in 1933 as the International Union Against Cancer. The organisation is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite and support the cancer community to reduce the global cancer burden, promote greater equity, and to ensure cancer control continues to be a priority in the world health and development agenda.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TNM Staging System","conceptCode":"C25384","definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3514-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"10544811","version":"1","preferredName":"Clinical Examination Stage Grouping","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._A formal or careful inspection of an object or subject._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"C25398:C131902:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Examination","conceptCode":"C131902","definition":"A formal or careful inspection of an object or subject.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26F6CD9-C705-67B3-E053-731AD00A073E","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"UICC Based:Staging Criteria Based on Union for International Cancer Control","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26F6CD9-C706-67B3-E053-731AD00A073E","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10672190","version":"1","preferredName":"Union for International Cancer Control Clinical Stage","preferredDefinition":"The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"10672190v1.00","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage 0","valueDescription":null,"ValueMeaning":{"publicId":"3203154","version":"1","preferredName":"Stage 0","longName":"3203154","preferredDefinition":"Cancer confined to the epithelium without invasion of the basement membrane.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0","conceptCode":"C28051","definition":"Cancer confined to the epithelium without invasion of the basement membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B867-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0AFD-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage 0a","valueDescription":null,"ValueMeaning":{"publicId":"3262280","version":"1","preferredName":"Stage 0a","longName":"3262280","preferredDefinition":"Cancer confined to the epithelium with formation of papillary structures without invasion of the basement membrane.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0a","conceptCode":"C27964","definition":"Cancer confined to the epithelium with formation of papillary structures without invasion of the basement membrane or noninvasive localized squamous cell carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAA19DDD-412D-ACAB-E040-BB89AD437AD0","latestVersionIndicator":"Yes","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0AFE-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage 0is","valueDescription":null,"ValueMeaning":{"publicId":"3262278","version":"1","preferredName":"Stage 0is","longName":"3262278","preferredDefinition":"Cancer confined to the epithelium with formation of a flat surface without invasion of the basement membrane.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0is","conceptCode":"C27965","definition":"Cancer confined to the epithelium with formation of a flat surface without invasion of the basement membrane.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAA19DDD-4107-ACAB-E040-BB89AD437AD0","latestVersionIndicator":"Yes","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0AFF-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage I","valueDescription":null,"ValueMeaning":{"publicId":"3179338","version":"1","preferredName":"Stage I","longName":"3179338","preferredDefinition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I","conceptCode":"C27966","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F8FD-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0B00-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IA","valueDescription":null,"ValueMeaning":{"publicId":"3179336","version":"1","preferredName":"Stage IA","longName":"3179336","preferredDefinition":"Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA","conceptCode":"C27975","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IA is defined as follows: T1, N0, M0. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IA is defined as follows: T1, N0, M0, G1, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F8DB-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0B01-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IA1","valueDescription":null,"ValueMeaning":{"publicId":"6078432","version":"1","preferredName":"Stage IA1","longName":"6078432","preferredDefinition":"A stage term referring to invasive cervical and lung cancer.  For cervical cancer, it includes: T1a1, N0, M0.  T1a1: Tumor with stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: (T1mi, N0, M0); (T1a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA1","conceptCode":"C27983","definition":"A stage term referring to invasive cervical and lung cancer.  For cervical cancer, it includes: T1a1, N0, M0.  T1a1: Tumor with stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: (T1mi, N0, M0); (T1a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D3F528-9C62-15B4-E053-F662850A8F81","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"COOPERM","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0B02-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IA2","valueDescription":null,"ValueMeaning":{"publicId":"6078431","version":"1","preferredName":"Stage IA2","longName":"6078431","preferredDefinition":"A stage term referring to invasive cervical cancer and invasive lung cancer. For cervical cancer, it includes: T1a2, N0, M0.  T1a2: Tumor with stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA2","conceptCode":"C27984","definition":"A stage term referring to invasive cervical cancer and invasive lung cancer. For cervical cancer, it includes: T1a2, N0, M0.  T1a2: Tumor with stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D3F528-9C3F-15B4-E053-F662850A8F81","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"COOPERM","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0B03-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IA3","valueDescription":null,"ValueMeaning":{"publicId":"6078434","version":"1","preferredName":"Stage IA3","longName":"6078434","preferredDefinition":"A stage term referring to invasive lung cancer. It includes: T1c, N0, M0. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA3","conceptCode":"C136485","definition":"A stage term referring to invasive lung cancer. It includes: T1c, N0, M0. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D3F528-9C88-15B4-E053-F662850A8F81","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0B04-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IB","valueDescription":null,"ValueMeaning":{"publicId":"3179333","version":"1","preferredName":"Stage IB","longName":"3179333","preferredDefinition":"Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB","conceptCode":"C27976","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IB is defined as follows: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IB is defined as follows: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F873-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0B05-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IB1","valueDescription":null,"ValueMeaning":{"publicId":"3225630","version":"1","preferredName":"Stage IB1","longName":"3225630","preferredDefinition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b1, N0, M0.  T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB1","conceptCode":"C28052","definition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b1, N0, M0. (partially adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-43F7-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444D895-0B06-06DA-E053-731AD00AD3AE","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IB2","valueDescription":null,"ValueMeaning":{"publicId":"3225629","version":"1","preferredName":"Stage IB2","longName":"3225629","preferredDefinition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b2, N0, M0.  T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB2","conceptCode":"C28053","definition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b2, N0, M0.  (partially adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-43D2-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7482-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IC","valueDescription":null,"ValueMeaning":{"publicId":"3179330","version":"1","preferredName":"Stage IC","longName":"3179330","preferredDefinition":"A cancer stage generally indicating the local invasion of tissues by cancer at the primary site.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IC","conceptCode":"C27981","definition":"A cancer stage generally indicating the local invasion of tissues by cancer at the primary site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F80B-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7483-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage II","valueDescription":null,"ValueMeaning":{"publicId":"3179329","version":"1","preferredName":"Stage II","longName":"3179329","preferredDefinition":"Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II","conceptCode":"C28054","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F7E9-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7484-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIA","valueDescription":null,"ValueMeaning":{"publicId":"3179328","version":"1","preferredName":"Stage IIA","longName":"3179328","preferredDefinition":"Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA","conceptCode":"C27967","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIA is defined as follows: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIA is defined as follows: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F7C7-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7485-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIA1","valueDescription":null,"ValueMeaning":{"publicId":"3522973","version":"1","preferredName":"Stage IIA1","longName":"3522973","preferredDefinition":"A stage term that applies to cervical cancer and indicates that the tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina. There is no parametrial invasion.  The lesion is clinically visible and measures 4.0 cm or less in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA1","conceptCode":"C95177","definition":"A stage term that applies to cervical cancer and indicates that the tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina. There is no parametrial invasion.  The lesion is clinically visible and measures 4.0 cm or less in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47FC0DE-5207-0CAF-E040-BB89AD43583B","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7486-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIA2","valueDescription":null,"ValueMeaning":{"publicId":"3522975","version":"1","preferredName":"Stage IIA2","longName":"3522975","preferredDefinition":"A stage term that applies to cervical cancer and indicates that the tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina. There is no parametrial invasion.  The lesion is clinically visible and measures more than 4.0 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA2","conceptCode":"C95178","definition":"A stage term that applies to cervical cancer and indicates that the tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina. There is no parametrial invasion.  The lesion is clinically visible and measures more than 4.0 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47FC0DE-522D-0CAF-E040-BB89AD43583B","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7487-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIB","valueDescription":null,"ValueMeaning":{"publicId":"3203159","version":"1","preferredName":"Stage IIB","longName":"3203159","preferredDefinition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIB is defined as follows: (T2, N1, MO); (T3, NO, MO). T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIB is defined as follows: T2, N0, M0, G3 , G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB","conceptCode":"C27968","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIB is defined as follows: (T2, N1, MO); (T3, NO, MO). T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIB is defined as follows: T2, N0, M0, G3, G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B921-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7488-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIC","valueDescription":null,"ValueMeaning":{"publicId":"3179327","version":"1","preferredName":"Stage IIC","longName":"3179327","preferredDefinition":"A cancer stage generally indicating the invasion of adjacent structures by cancer without distant metastases.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIC","conceptCode":"C27969","definition":"A cancer stage generally indicating the invasion of adjacent structures by cancer without distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F755-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-7489-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIC1","valueDescription":null,"ValueMeaning":{"publicId":"10672191","version":"1","preferredName":"FIGO Stage IIC1","longName":"10672191v1.00","preferredDefinition":"A stage term that refers to FIGO stage II cervical cancer with metastasis to one or two lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIC1","conceptCode":"C188300","definition":"A stage term that refers to FIGO stage II cervical cancer with metastasis to one or two lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E444E549-7481-080D-E053-731AD00A1ABA","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-748A-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage III","valueDescription":null,"ValueMeaning":{"publicId":"3203160","version":"1","preferredName":"Stage III","longName":"3203160","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III","conceptCode":"C27970","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B94F-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444E549-748B-080D-E053-731AD00A1ABA","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIIA","valueDescription":null,"ValueMeaning":{"publicId":"3203161","version":"1","preferredName":"Stage IIIA","longName":"3203161","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.\r\nThe definition of stage IIIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIA is defined as follows: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIA is defined as follows: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA","conceptCode":"C27977","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites. The definition of stage IIIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIA is defined as follows: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIA is defined as follows: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B972-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D955-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIIB","valueDescription":null,"ValueMeaning":{"publicId":"3203162","version":"1","preferredName":"Stage IIIB","longName":"3203162","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIB is defined as follows: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIB is defined as follows: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB","conceptCode":"C27978","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIB is defined as follows: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIB is defined as follows: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B995-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D956-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIIC","valueDescription":null,"ValueMeaning":{"publicId":"3203163","version":"1","preferredName":"Stage IIIC","longName":"3203163","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC","conceptCode":"C27982","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B9B8-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D957-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIIC1","valueDescription":null,"ValueMeaning":{"publicId":"6027533","version":"1","preferredName":"Stage IIIC1","longName":"6027533","preferredDefinition":"A stage term that applies to uterine corpus cancer and indicates that the tumor is confined to the corpus uteri, or it invades the stromal connective tissue of the cervix but does not extend beyond the uterus, or it involves serosa and/or adnexa, vagina, or parametrial tissue. There is regional lymph node metastasis to the pelvic lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC1","conceptCode":"C95179","definition":"A stage term that applies to uterine corpus cancer and indicates that the tumor is confined to the corpus uteri, or it invades the stromal connective tissue of the cervix but does not extend beyond the uterus, or it involves serosa and/or adnexa, vagina, or parametrial tissue. There is regional lymph node metastasis to the pelvic lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D92F127-8D2B-406B-E053-F662850AB26D","latestVersionIndicator":"Yes","beginDate":"2017-11-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D958-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IIIC2","valueDescription":null,"ValueMeaning":{"publicId":"6027531","version":"1","preferredName":"Stage IIIC2","longName":"6027531","preferredDefinition":"A stage term that applies to uterine corpus cancer and indicates that the tumor is confined to the corpus uteri, or it invades stromal connective tissue of the cervix but does not extend beyond the uterus, or it involves serosa and/or adnexa, vagina, or parametrial tissue.  There is regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC2","conceptCode":"C95180","definition":"A stage term that applies to uterine corpus cancer and indicates that the tumor is confined to the corpus uteri, or it invades stromal connective tissue of the cervix but does not extend beyond the uterus, or it involves serosa and/or adnexa, vagina, or parametrial tissue.  There is regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D92F127-8D05-406B-E053-F662850AB26D","latestVersionIndicator":"Yes","beginDate":"2017-11-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D959-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IS","valueDescription":null,"ValueMeaning":{"publicId":"4339265","version":"1","preferredName":"Stage Is","longName":"4339265","preferredDefinition":"Testicular cancer found in the testicle, spermatic cord and scrotum, associated with slightly elevated levels of all tumor markers or moderately/highly elevated levels of one or more tumor markers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IS","conceptCode":"C28285","definition":"Testicular cancer found in the testicle, spermatic cord and scrotum, associated with slightly elevated levels of all tumor markers or moderately/highly elevated levels of one or more tumor markers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAA223A1-4601-E4F0-E040-BB89AD436356","latestVersionIndicator":"Yes","beginDate":"2014-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D95A-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":null,"ValueMeaning":{"publicId":"3203164","version":"1","preferredName":"Stage IV","longName":"3203164","preferredDefinition":"Cancer that has spread to distant anatomic sites beyond its original site of growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV","conceptCode":"C27971","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B9DB-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D95B-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IVA","valueDescription":null,"ValueMeaning":{"publicId":"3203165","version":"1","preferredName":"Stage IVA","longName":"3203165","preferredDefinition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVA depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVA is defined as follows: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung; for vaginal cancer, stage IVA is defined as follows: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA","conceptCode":"C27979","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVA depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVA is defined as follows: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung; for vaginal cancer, stage IVA is defined as follows: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B9FE-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D95C-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IVB","valueDescription":null,"ValueMeaning":{"publicId":"3203166","version":"1","preferredName":"Stage IVB","longName":"3203166","preferredDefinition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVB depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVB is defined as follows: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites; for vaginal cancer, stage IVB is defined as follows:  Any T, Any N, M1. M1: Distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB","conceptCode":"C27980","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVB depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVB is defined as follows: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites; for vaginal cancer, stage IVB is defined as follows: Any T, Any N, M1. M1: Distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-BA21-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D95D-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage IVC","valueDescription":null,"ValueMeaning":{"publicId":"3248483","version":"1","preferredName":"Stage IVC","longName":"3248483","preferredDefinition":"Cancer that has spread to distant anatomic sites beyound its original site of growth.  The definition of stage IVC depends on the particular type of cancer that it refers to; for example, for head and neck carcinomas (lip and oral cavity carcinoma, laryngeal carcinoma, nasal cavity and paranasal sinus carcinoma, pharynx carcinoma, thyroid gland carcinoma, and mjor salivery gland carcinoma) and head and neck mucosal melanoma, stage IVC is defined as follows: any T, any N, M1; for appendix carcinoma, stage IVC is defined as follow: any T, any N, M1b, any G. M1: Distant metastasis. M1b: Nonperitoneal metastasis. G: Grade (celllar differentiation).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVC","conceptCode":"C28055","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVC depends on the particular type of cancer that it refers to; for example, for head and neck carcinomas (lip and oral cavity carcinoma, laryngeal carcinoma, nasal cavity and paranasal sinus carcinoma, pharynx carcinoma, thyroid gland carcinoma, and major salivary gland carcinoma) and head and neck mucosal melanoma, stage IVC is defined as follows: any T, any N, M1; for appendix carcinoma, stage IVC is defined as follows: any T, any N, M1b, any G. M1: Distant metastasis.  M1b: Nonperitoneal metastasis.  G: Grade (cellular differentiation).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-166A-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F284-D95E-098E-E053-731AD00A105E","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage Tis","valueDescription":null,"ValueMeaning":{"publicId":"3201442","version":"1","preferredName":"Breast Cancer pTis TNM Finding v6 and v7","longName":"3201442v1.00","preferredDefinition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EC4-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F712-937F-0A07-E053-731AD00A054D","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Stage X","valueDescription":null,"ValueMeaning":{"publicId":"3203153","version":"1","preferredName":"Stage X","longName":"3203153","preferredDefinition":"A stage term that is applied to patients who have not been evaluated, but are presumed to have cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage X","conceptCode":"C95957","definition":"A stage term that is applied to patients who have not been evaluated, but are presumed to have cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B830-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F712-9380-0A07-E053-731AD00A054D","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"4266671","version":"1","preferredName":"Unknown","longName":"4266671","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C00C1A-0A55-5623-E040-BB89AD4375BC","latestVersionIndicator":"Yes","beginDate":"2014-04-11","endDate":null,"createdBy":"DWARZEL","dateCreated":"2014-04-11","modifiedBy":"COLBERTM","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F712-9381-0A07-E053-731AD00A054D","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E444F712-9382-0A07-E053-731AD00A054D","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E444B64D-BB50-0271-E053-731AD00A5723","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"UICC Clinical Stage","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E44589C3-3492-194E-E053-731AD00A2990","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}